UBS Group
BIOX icon

UBS Group’s Bioceres Crop Solutions BIOX Stock Holding History

UBS Group’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
408,276
+50,115
+14% +$23.6K ﹤0.01% 6988
2026
Q1 		$159K Buy
358,161
+263,634
+279% +$200K ﹤0.01% 6762
2025
Q4 		$124K Buy
94,527
+78,722
+498% +$126K ﹤0.01% 6802
2025
Q3 		$22.3K Sell
15,805
-32,878
-68% -$100K ﹤0.01% 8085
2025
Q2 		$218K Sell
48,683
-43,628
-47% -$197K ﹤0.01% 6662
2025
Q1 		$421K Buy
92,311
+46,882
+103% +$258K ﹤0.01% 5986
2024
Q4 		$276K Buy
45,429
+30,717
+209% +$210K ﹤0.01% 6250
2024
Q3 		$116K Sell
14,712
-41,006
-74% -$414K ﹤0.01% 6251
2024
Q2 		$625K Buy
55,718
+33,842
+155% +$395K ﹤0.01% 4827
2024
Q1 		$277K Sell
21,876
-6,878
-24% -$90.6K ﹤0.01% 5633
2023
Q4 		$395K Sell
28,754
-8,749
-23% -$102K ﹤0.01% 5295
2023
Q3 		$423K Sell
37,503
-8,361
-18% -$100K ﹤0.01% 4784
2023
Q2 		$613K Buy
45,864
+8,396
+22% +$98.4K ﹤0.01% 4658
2023
Q1 		$435K Buy
37,468
+1,676
+5% +$19.7K ﹤0.01% 4801
2022
Q4 		$431K Buy
35,792
+8,299
+30% +$108K ﹤0.01% 4836
2022
Q3 		$358K Buy
27,493
+5,412
+25% +$66.4K ﹤0.01% 4625
2022
Q2 		$302K Buy
+22,081
New +$293K ﹤0.01% 4619
2021
Q1 		– Sell
-3,218
Closed -$20K – 8999
2020
Q4 		$20K Buy
+3,218
New +$18.3K ﹤0.01% 6934
2020
Q3 		– Sell
-7,646
Closed -$46K – 7982
2020
Q2 		$46K Buy
+7,646
New +$43.8K ﹤0.01% 5913

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group's BIOX Position: Q2 2026 in Review

UBS Group increased its Bioceres Crop Solutions (BIOX) stake by 14% in Q2 2026, buying an estimated $23.6K and bringing the position to 408,276 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #6988.

UBS Group first reported a position in BIOX in Q2 2020 and has held it in 19 quarters since. The position peaked at $625K in Q2 2024. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

  • UBS Group held 408,276 shares of Bioceres Crop Solutions worth $143K as of Q2 2026.
  • UBS Group bought 50,115 Bioceres Crop Solutions shares in Q2 2026, an estimated $23.6K.
  • Bioceres Crop Solutions made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6988 holding.
  • UBS Group first reported a position in Bioceres Crop Solutions in Q2 2020 and has held it in 19 quarters since.
  • UBS Group's Bioceres Crop Solutions position peaked at $625K in Q2 2024.
  • 28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.